FDA Approved: CYCLOBENZAPRINE HYDROCHLORIDE — Supplemental Application (Solco Healthcare U.S., LLC)

View source ↗

Summary

FDA approves a supplemental application for Cyclobenzaprine Hydrochloride (Solco Healthcare U.S., LLC), authorizing the generic product to be marketed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle Spasm
• Musculoskeletal Pain

Drugs mentioned

• CYCLOBENZAPRINE HYDROCHLORIDE (Cyclobenzaprine hydrochloride)

Snippet

SUPPL AP for CYCLOBENZAPRINE HYDROCHLORIDE (CYCLOBENZAPRINE HYDROCHLORIDE)